Reduced prevalence of late-diabetic complications in MODY3 with early diagnosis.
Sagen
J V
JV
Njølstad
P R
PR
Søvik
O
O
D000328:Adult; D017668:Age of Onset; D004268:DNA-Binding Proteins; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis* / Q000235:genetics; D006442:Glycated Hemoglobin / Q000031:analogs & derivatives* / Q000032:analysis; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D006801:Humans; D009154:Mutation / Q000235:genetics; D009687:Nuclear Proteins; D013997:Time Factors; D014157:Transcription Factors / Q000235:genetics*
D004268:DNA-Binding Proteins; D006442:Glycated Hemoglobin; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D009687:Nuclear Proteins; D014157:Transcription Factors; C496487:HNF1A protein, human; C496495:HNF1B protein, human; C025617:glucosylated hemoglobin A